Photo taken from Massimo Cristofanilli/X
Apr 13, 2024, 07:26
Massimo Cristofanilli: Development of endocrine resistance can be associated with loss of ER expression in CTCs
Massimo Cristofanilli, at Weill Cornell Medicine, shared a post by Dana-Farber’s Breast Oncology Center, on X, adding:
“Development of endocrine resistance can be associated with loss of ER expression in CTCs. Expanding liquid biopsy assessment in HR+ MBC. ”
Quoting Dana-Farber’s Breast Oncology Center’s post:
“Results of the Phase II PACE Study: Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- Metastatic Breast Cancer were presented at AACR24.”
Read further.
Source: Massimo Cristofanilli/X and Dana-Farber’s Breast Oncology Center/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 11:56
Nov 14, 2024, 11:49
Nov 14, 2024, 11:46
Nov 14, 2024, 11:38
Nov 14, 2024, 11:30
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15